Advanced Solid Cancers (DBCOND0034918)
Identifiers
- Synonyms
- Advanced Solid Cancer
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT03254732 Study ADI-PEG 20 Plus Pembrolizumab in Advanced Solid Cancers treatment 1 terminated NCT02694822 AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Subjects With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy treatment 1 / 2 completed NCT03956680 An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers treatment 1 completed NCT00478101 Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain supportive_care 2 completed NCT01019941 Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer treatment 1 completed NCT02792465 A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors treatment 1 active_not_recruiting NCT00886782 A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors treatment 1 / 2 terminated NCT00337376 A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers treatment 1 terminated NCT03512340 Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers treatment 1 completed NCT03884517 Clinical Trial of BAT8003 (for Injection) for Patients With Advanced Epithelial Cancer No drug interventions treatment 1 terminated NCT04877717 A Study of SHR-A1904 in Patients With Advanced Solid Cancer treatment 1 unknown_status NCT05947474 ORB-011 In Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03917043 APG-2449 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03618043 Safety and Tolerability of SH-1028 in Patients With Advanced Solid Cancer No drug interventions treatment 1 unknown_status NCT03791112 A Phase I Study of BPI-16350 in Patients With Advanced Solid Tumor No drug interventions treatment 1 recruiting NCT05770310 A Phase I Study Of JS015 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01416623 A Phase I Study of Henatinib in Patients With Advanced Solid Malignancies treatment 1 terminated